General Information of the Compound
| Compound ID |
CP0433003
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(7E)-1-(2,4-dichlorophenyl)-5-(2-imidazol-1-ylacetyl)-7-[(4-methoxyphenyl)methylidene]-N-[(1R)-1-phenylethyl]-4,6-dihydropyrazolo[4,3-c]pyridine-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H30Cl2N6O3
|
||||||||||||||||||
| Molecular Weight |
641.559
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(\C=C2/CN(Cc3c(nn(c23)-c2ccc(Cl)cc2Cl)C(=O)N[C@H](C)c2ccccc2)C(=O)Cn2ccnc2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H30Cl2N6O3/c1-22(24-6-4-3-5-7-24)38-34(44)32-28-19-41(31(43)20-40-15-14-37-21-40)18-25(16-23-8-11-27(45-2)12-9-23)33(28)42(39-32)30-13-10-26(35)17-29(30)36/h3-17,21-22H,18-20H2,1-2H3,(H,38,44)/b25-16+/t22-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
YTPBKNZXOGXDKV-NJRDNMGOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Protein ID: PT00834, Cannabinoid receptor 2